261 related articles for article (PubMed ID: 20635830)
1. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polytherapy on an inpatient psychiatric unit: how does clinical practice coincide with Joint Commission guidelines?
Huffman JC; Chang TE; Durham LE; Weiss AP
Gen Hosp Psychiatry; 2011; 33(5):501-8. PubMed ID: 21762994
[TBL] [Abstract][Full Text] [Related]
4. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
5. Improving the success of mailed letter intervention programs to influence prescribing behaviors: a review.
Ho MJ; Venci J
J Manag Care Pharm; 2012 Oct; 18(8):627-49. PubMed ID: 23127150
[TBL] [Abstract][Full Text] [Related]
6. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.
Kogut SJ; Yam F; Dufresne R
J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230
[TBL] [Abstract][Full Text] [Related]
7. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
9. The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients.
Lochmann van Bennekom MWH; Gijsman HJ; Groenewoud H; Verkes RJ
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):129-134. PubMed ID: 33666400
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.
Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J
Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062
[TBL] [Abstract][Full Text] [Related]
11. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
12. Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy.
Brunette MF; Cotes RO; de Nesnera A; McHugo G; Dzebisashvili N; Xie H; Bartels SJ
Psychiatr Serv; 2018 Sep; 69(9):1021-1028. PubMed ID: 29879874
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
Paton C; Bhatti S; Purandare K; Roy A; Barnes T
BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
[TBL] [Abstract][Full Text] [Related]
15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
16. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
17. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.
Kroken RA; Johnsen E; Ruud T; Wentzel-Larsen T; Jørgensen HA
BMC Psychiatry; 2009 May; 9():24. PubMed ID: 19445700
[TBL] [Abstract][Full Text] [Related]
18. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
19. Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of Ferrara.
Bianchi S; Bianchini E; Scanavacca P
BMC Clin Pharmacol; 2011 Dec; 11():21. PubMed ID: 22185397
[TBL] [Abstract][Full Text] [Related]
20. Explicit versus implicit review to explore combination antipsychotic prescribing.
Wheeler A
J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]